The Small Cap Investor
"In The World of Investments, Knowledge is Power"
 
Register
Login
TSCI Small Cap Report
  Get Quote
  
 

 
  Stocks In The News
 
 
  Research Spotlight
 
 
Chemaphor, Inc. (TSX-V: CFR)
 

Equity Research Available: Chemaphor Research Library

Chemaphor Inc. (TSX-V: CFR) is a biotechnology company operating in the animal and human health marketplaces. Its proprietary products are designed to provide improvements in health for pets (dogs, cats & horses) and, eventually, humans. The Company currently sells its products, i.e., Oximunol™ Chewable Tablets and its in-licensed Vet-Stem™ Regenerative Cell Therapy, to consumers through the veterinary clinic channel.

However, Chemaphor is not just about pet wellness as the Company is also involved in livestock health and productivity enhancement. In particular, Chemaphor is developing a line of feed additives, specifically for the poultry, swine and, potentially, fish producers. Revenue contribution is expected in about four years, which is about the timeline required to receive necessary government approvals.

Chemaphor is on the brink of profitability and its transition towards achieving a positive “net earnings” status is being driven by the initiation of revenue from its pet-wellness products and orchestrated by the experienced executive talent recently hired from the animal health market industry. This is supported by the growing number of dogs and cats as companion pets, the concomitant growth in the natural-health market for pets, and the equally increasing importance of veterinarian clinics as a pet-wellness distribution network. Chemaphor is leveraging off all three of these growth drivers. 

 
 
  TSCI Street PulseMore
 


Paul Silver, Wall Street Resources
September 15, 2011 - Bifurcating crude oil’s two VIP’s, why is WTI getting whacked?
Read More


Bob Weir, eResearch
September 19, 2011 - Mining In Quebec
Read More


Heidi L. Evans, SmallCapVoice.com
November 26, 2011 - Exergetic Energy Seeks to Provide Energy Solutions
Read More
 
 
  TSCI Subscriber's VoiceMore
 
frosique

Many thanks for the free subscription. Kind Regards. F.Rosique
Read More
dcartercpa

Congratulations to TSCIeditor for alerting members to OPRX at $0.80 per share back on May
Read More
 
 
  The Markets
 
  News From Main Street
   
M3 Investor Relations
Do you have a quarterback for your IR program?  ... Why not?
 
   
 
  Taglich Brothers
Independent Small Cap Research
 
  SmallCapVoice.com
Hear from CEO, CFO, COO, Analysts and other leading authorities in the Small Cap Market.
 
  AlphaTrade: E-Gate
Comprehensive, affordable stock quote service offering real time data for your computer or mobile device.
 
   
eResearch
MUST READ research in the mining, energy, oil/gas sectors!  Huge coverage of Canadian issuers.
HOME   |    RESEARCH   |    QUOTES   |    ABOUT TSCI   |    PRIVACY POLICY    |    CONTRIBUTORS    |    ADVERTISING   |    DISCLOSURE   |    CONTACT US   |    TERMS OF USE
Copyright 2011. The Small Cap Investor LLC. All Rights Reserved.